Data
Lookout
Search
Browse
Diseases
Sponsors
Pipeline Pulse
Weekly Report
Watchlist
Blog
Pricing
Sign In
Home
NCT03925714
Clinical Trial
Impact of P53 and SIRT1 in Type 2 Diabetes
Recruiting
Phase 3
View on ClinicalTrials.gov →
Summary
Investigating the impact of p53 and SIRT1 in the development of type 2 DM
Trial Details
NCT Number
NCT03925714
Lead Sponsor
Sherief Abd-Elsalam
Conditions
DM
Enrollment
90 participants
Start Date
2019-04-01
Primary Completion
2028-12
(estimated)
Study Completion
2028-12
(estimated)
Updated on ClinicalTrials.gov
2019-04-24